SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-258874
Filing Date
2024-11-14
Accepted
2024-11-14 18:01:27
Documents
1
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCMOEZ KASSAMTONY MOORE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d886582dsc13ga.htm SC 13G/A 117986
  Complete submission text file 0001193125-24-258874.txt   119911
Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Subject) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93211 | Film No.: 241464864
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)